<code id='AA2B670380'></code><style id='AA2B670380'></style>
    • <acronym id='AA2B670380'></acronym>
      <center id='AA2B670380'><center id='AA2B670380'><tfoot id='AA2B670380'></tfoot></center><abbr id='AA2B670380'><dir id='AA2B670380'><tfoot id='AA2B670380'></tfoot><noframes id='AA2B670380'>

    • <optgroup id='AA2B670380'><strike id='AA2B670380'><sup id='AA2B670380'></sup></strike><code id='AA2B670380'></code></optgroup>
        1. <b id='AA2B670380'><label id='AA2B670380'><select id='AA2B670380'><dt id='AA2B670380'><span id='AA2B670380'></span></dt></select></label></b><u id='AA2B670380'></u>
          <i id='AA2B670380'><strike id='AA2B670380'><tt id='AA2B670380'><pre id='AA2B670380'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:2814
          Adobe

          Hospitals and medical groups say they’re still reeling from the effects of the cyberattack on a UnitedHealth Group subsidiary, but the massive company at the center of the debacle has so far emerged largely unscathed, with executives on Tuesday praising its strength and resilience.

          The almost $8 billion UnitedHealth made on operations in the first three months of 2024 was roughly the same as the prior-year period. Despite the Change Healthcare cyberattack, the health insurance, provider, and technology conglomerate reaffirmed its adjusted earnings outlook for the year, and its share price grew more than 5% by market close.

          advertisement

          Ultimately, UnitedHealth said it’ll take an up to $1.6 billion hit from the cyberattack this year, a drop in the bucket for a company that’s expected to generate $400 billion in revenue.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          In venture capital firm's success, lessons for turning crisis into profit
          In venture capital firm's success, lessons for turning crisis into profit

          AdobeThisarticleisadaptedfromSTAT’slatestreport,“2023Update:rankingbiotech’stopventurecapitalfirms.”

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Three trends to watch in biotech in 2024

          ChristineKao/STATEverywinter,likePunxsutawneynobles,biotech’smanythoughtleadersgatherfortheJ.P.Morga